title: The evaluation of drug rechallenge: the casopitant Phase III program.
authors.affiliation: GlaxoSmithKline, RTP, Durham, NC 27709, USA. Christine.M.Hunt@gsk.com
authors.forename: Christine M
authors.initials: CM
authors.lastname: Hunt
authors.forename: Julie I
authors.initials: JI
authors.lastname: Papay
authors.forename: Donna S
authors.initials: DS
authors.lastname: Rich
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Abissi
authors.forename: Mark W
authors.initials: MW
authors.lastname: Russo